Decreased Expression and Activity of P-GIycoprotein in Rat Liver During Acute Inflammation
Authors:
- Micheline Piquette-MillerMPMicheline Piquette-Miller
- Anne PakAPAnne Pak
- 1 May 1998
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (5) , 706-711
Abstract
Purpose. Drug disposition is often altered in inflammatory disease. Although the influence of inflammation on hepatic drug metabolism and protein binding has been well studied, its impact on drug...Keywords
This publication has 30 references indexed in Scilit:
- Characterization of the promoter region of the human MDR3 P-glycoprotein geneBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1995
- Isolation of rat pgp3 cDNA: evidence for gender and zonal regulation of expression in the liverBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liverBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1994
- Influence of cytokines onmdr1 expression in human colon carcinoma cell lines: Increased cytoxicity of MDR relevant drugsJournal of Cancer Research and Clinical Oncology, 1994
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- Agonists and antagonists for lipopolysaccharide-induced cytokinesImmunobiology, 1993
- Regulation of 2‐acetylaminofluorene‐and 3‐methylcholanthrene‐mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liverMolecular Carcinogenesis, 1991
- Overexpression of P-glycoprotein in Mammalian Tumor Cell Lines After Fractionated X Irradiation In VitroJNCI: Journal of the National Cancer Institute, 1990
- EFFECT OF TURPENTINE‐INDUCED INFLAMMATION ON THE DISPOSITION KINETICS OF PROPRANOLOL, METOPROLOL, AND ANTIPYRINE IN THE RATFundamental & Clinical Pharmacology, 1989
- Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.BMJ, 1976